|
KIAA0247 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.611600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.441700E-03 |
| Normal-vs-Stage2 |
7.354600E-01 |
| Normal-vs-Stage3 |
3.349600E-01 |
| Normal-vs-Stage4 |
9.444000E-02 |
| Stage1-vs-Stage2 |
6.987600E-02 |
| Stage1-vs-Stage3 |
3.239200E-03 |
| Stage1-vs-Stage4 |
8.030100E-04 |
| Stage2-vs-Stage3 |
8.047200E-01 |
| Stage2-vs-Stage4 |
3.932000E-01 |
| Stage3-vs-Stage4 |
3.982200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.031800E-01 |
| Normal-vs-AfricanAmerican |
7.414600E-01 |
| Normal-vs-Asian |
2.379600E-01 |
| Caucasian-vs-AfricanAmerican |
4.174200E-01 |
| Caucasian-vs-Asian |
3.136400E-01 |
| AfricanAmerican-vs-Asian |
2.760000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.902200E-01 |
| Normal-vs-Female |
7.264300E-02 |
| Male-vs-Female |
4.813700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.377200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.445600E-02 |
| Normal-vs-Age(61-80Yrs) |
6.108800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.445000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.213210E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.101000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.828200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.204090E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.031800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.751600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.185000E-03 |
| Normal-vs-Grade 2 |
2.450300E-02 |
| Normal-vs-Grade 3 |
7.775600E-01 |
| Normal-vs-Grade 4 |
1.823780E-02 |
| Grade 1-vs-Grade 2 |
3.142300E-02 |
| Grade 1-vs-Grade 3 |
2.398900E-03 |
| Grade 1-vs-Grade 4 |
1.997700E-04 |
| Grade 2-vs-Grade 3 |
1.887640E-02 |
| Grade 2-vs-Grade 4 |
1.759820E-04 |
| Grade 3-vs-Grade 4 |
3.308100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.552600E-04 |
| Normal-vs-ccB subtype |
2.953200E-01 |
| ccA subtype-vs-ccB subtype |
3.96390000000357E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.206180E-01 |
| Normal-vs-N1 |
1.058570E-01 |
| N0-vs-N1 |
3.462400E-02 |
|
|
